 The purpose of this pivotal study is to provide prospective evidence that the SentiMagSiennaXP is safe and non-inferior to the current standard of care for lymph node localization in patients with breast cancer as part of a sentinel lymph node biopsy SLNB procedure and to summarize measures of product safety and performance. 